The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Artificial Vascular Grafts Market Research Report 2025
Synopsis
Artificial Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.
The global Artificial Vascular Grafts market was valued at US$ 3620.8 million in 2023 and is anticipated to reach US$ 4621.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Artificial Vascular Grafts, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Vascular Grafts.
Report Scope
The Artificial Vascular Grafts market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Vascular Grafts market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Vascular Grafts manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Getinge
Bard PV
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Maquet
AORTEC
CryoLife
LifeNet Health
Segment by Type
ePTFE Vascular Graft
Polyester Vascular Graft
PTFE Vascular Graft
Others
Segment by Application
Cardiovascular Diseases
Aneurysm
Vascular Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Vascular Grafts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Vascular Grafts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Artificial Vascular Grafts are used to replace, bypass or maintain function of damaged, occluded or diseased blood vessels in small, medium and large diameter.
The global Artificial Vascular Grafts market was valued at US$ 3620.8 million in 2023 and is anticipated to reach US$ 4621.8 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Artificial Vascular Grafts, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Vascular Grafts.
Report Scope
The Artificial Vascular Grafts market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Artificial Vascular Grafts market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Vascular Grafts manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Getinge
Bard PV
Terumo
W. L. Gore
Japan Lifeline
B.Braun
LeMaitre Vascular
Suokang
Chest Medical
Maquet
AORTEC
CryoLife
LifeNet Health
Segment by Type
ePTFE Vascular Graft
Polyester Vascular Graft
PTFE Vascular Graft
Others
Segment by Application
Cardiovascular Diseases
Aneurysm
Vascular Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Artificial Vascular Grafts manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Artificial Vascular Grafts in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Artificial Vascular Grafts Market Overview
1.1 Product Overview and Scope of Artificial Vascular Grafts
1.2 Artificial Vascular Grafts Segment by Type
1.2.1 Global Artificial Vascular Grafts Market Value Comparison by Type (2024-2030)
1.2.2 ePTFE Vascular Graft
1.2.3 Polyester Vascular Graft
1.2.4 PTFE Vascular Graft
1.2.5 Others
1.3 Artificial Vascular Grafts Segment by Application
1.3.1 Global Artificial Vascular Grafts Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Diseases
1.3.3 Aneurysm
1.3.4 Vascular Occlusion
1.3.5 Others
1.4 Global Artificial Vascular Grafts Market Size Estimates and Forecasts
1.4.1 Global Artificial Vascular Grafts Revenue 2019-2030
1.4.2 Global Artificial Vascular Grafts Sales 2019-2030
1.4.3 Global Artificial Vascular Grafts Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Artificial Vascular Grafts Market Competition by Manufacturers
2.1 Global Artificial Vascular Grafts Sales Market Share by Manufacturers (2019-2024)
2.2 Global Artificial Vascular Grafts Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Artificial Vascular Grafts Average Price by Manufacturers (2019-2024)
2.4 Global Artificial Vascular Grafts Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Artificial Vascular Grafts, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Artificial Vascular Grafts, Product Type & Application
2.7 Artificial Vascular Grafts Market Competitive Situation and Trends
2.7.1 Artificial Vascular Grafts Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Artificial Vascular Grafts Players Market Share by Revenue
2.7.3 Global Artificial Vascular Grafts Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Artificial Vascular Grafts Retrospective Market Scenario by Region
3.1 Global Artificial Vascular Grafts Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Artificial Vascular Grafts Global Artificial Vascular Grafts Sales by Region: 2019-2030
3.2.1 Global Artificial Vascular Grafts Sales by Region: 2019-2024
3.2.2 Global Artificial Vascular Grafts Sales by Region: 2025-2030
3.3 Global Artificial Vascular Grafts Global Artificial Vascular Grafts Revenue by Region: 2019-2030
3.3.1 Global Artificial Vascular Grafts Revenue by Region: 2019-2024
3.3.2 Global Artificial Vascular Grafts Revenue by Region: 2025-2030
3.4 North America Artificial Vascular Grafts Market Facts & Figures by Country
3.4.1 North America Artificial Vascular Grafts Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Artificial Vascular Grafts Sales by Country (2019-2030)
3.4.3 North America Artificial Vascular Grafts Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Artificial Vascular Grafts Market Facts & Figures by Country
3.5.1 Europe Artificial Vascular Grafts Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Artificial Vascular Grafts Sales by Country (2019-2030)
3.5.3 Europe Artificial Vascular Grafts Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Artificial Vascular Grafts Market Facts & Figures by Country
3.6.1 Asia Pacific Artificial Vascular Grafts Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Artificial Vascular Grafts Sales by Country (2019-2030)
3.6.3 Asia Pacific Artificial Vascular Grafts Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Artificial Vascular Grafts Market Facts & Figures by Country
3.7.1 Latin America Artificial Vascular Grafts Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Artificial Vascular Grafts Sales by Country (2019-2030)
3.7.3 Latin America Artificial Vascular Grafts Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Artificial Vascular Grafts Market Facts & Figures by Country
3.8.1 Middle East and Africa Artificial Vascular Grafts Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Artificial Vascular Grafts Sales by Country (2019-2030)
3.8.3 Middle East and Africa Artificial Vascular Grafts Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Artificial Vascular Grafts Sales by Type (2019-2030)
4.1.1 Global Artificial Vascular Grafts Sales by Type (2019-2024)
4.1.2 Global Artificial Vascular Grafts Sales by Type (2025-2030)
4.1.3 Global Artificial Vascular Grafts Sales Market Share by Type (2019-2030)
4.2 Global Artificial Vascular Grafts Revenue by Type (2019-2030)
4.2.1 Global Artificial Vascular Grafts Revenue by Type (2019-2024)
4.2.2 Global Artificial Vascular Grafts Revenue by Type (2025-2030)
4.2.3 Global Artificial Vascular Grafts Revenue Market Share by Type (2019-2030)
4.3 Global Artificial Vascular Grafts Price by Type (2019-2030)
5 Segment by Application
5.1 Global Artificial Vascular Grafts Sales by Application (2019-2030)
5.1.1 Global Artificial Vascular Grafts Sales by Application (2019-2024)
5.1.2 Global Artificial Vascular Grafts Sales by Application (2025-2030)
5.1.3 Global Artificial Vascular Grafts Sales Market Share by Application (2019-2030)
5.2 Global Artificial Vascular Grafts Revenue by Application (2019-2030)
5.2.1 Global Artificial Vascular Grafts Revenue by Application (2019-2024)
5.2.2 Global Artificial Vascular Grafts Revenue by Application (2025-2030)
5.2.3 Global Artificial Vascular Grafts Revenue Market Share by Application (2019-2030)
5.3 Global Artificial Vascular Grafts Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Getinge
6.1.1 Getinge Corporation Information
6.1.2 Getinge Description and Business Overview
6.1.3 Getinge Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Getinge Artificial Vascular Grafts Product Portfolio
6.1.5 Getinge Recent Developments/Updates
6.2 Bard PV
6.2.1 Bard PV Corporation Information
6.2.2 Bard PV Description and Business Overview
6.2.3 Bard PV Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bard PV Artificial Vascular Grafts Product Portfolio
6.2.5 Bard PV Recent Developments/Updates
6.3 Terumo
6.3.1 Terumo Corporation Information
6.3.2 Terumo Description and Business Overview
6.3.3 Terumo Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Terumo Artificial Vascular Grafts Product Portfolio
6.3.5 Terumo Recent Developments/Updates
6.4 W. L. Gore
6.4.1 W. L. Gore Corporation Information
6.4.2 W. L. Gore Description and Business Overview
6.4.3 W. L. Gore Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.4.4 W. L. Gore Artificial Vascular Grafts Product Portfolio
6.4.5 W. L. Gore Recent Developments/Updates
6.5 Japan Lifeline
6.5.1 Japan Lifeline Corporation Information
6.5.2 Japan Lifeline Description and Business Overview
6.5.3 Japan Lifeline Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Japan Lifeline Artificial Vascular Grafts Product Portfolio
6.5.5 Japan Lifeline Recent Developments/Updates
6.6 B.Braun
6.6.1 B.Braun Corporation Information
6.6.2 B.Braun Description and Business Overview
6.6.3 B.Braun Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.6.4 B.Braun Artificial Vascular Grafts Product Portfolio
6.6.5 B.Braun Recent Developments/Updates
6.7 LeMaitre Vascular
6.6.1 LeMaitre Vascular Corporation Information
6.6.2 LeMaitre Vascular Description and Business Overview
6.6.3 LeMaitre Vascular Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LeMaitre Vascular Artificial Vascular Grafts Product Portfolio
6.7.5 LeMaitre Vascular Recent Developments/Updates
6.8 Suokang
6.8.1 Suokang Corporation Information
6.8.2 Suokang Description and Business Overview
6.8.3 Suokang Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Suokang Artificial Vascular Grafts Product Portfolio
6.8.5 Suokang Recent Developments/Updates
6.9 Chest Medical
6.9.1 Chest Medical Corporation Information
6.9.2 Chest Medical Description and Business Overview
6.9.3 Chest Medical Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Chest Medical Artificial Vascular Grafts Product Portfolio
6.9.5 Chest Medical Recent Developments/Updates
6.10 Maquet
6.10.1 Maquet Corporation Information
6.10.2 Maquet Description and Business Overview
6.10.3 Maquet Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Maquet Artificial Vascular Grafts Product Portfolio
6.10.5 Maquet Recent Developments/Updates
6.11 AORTEC
6.11.1 AORTEC Corporation Information
6.11.2 AORTEC Artificial Vascular Grafts Description and Business Overview
6.11.3 AORTEC Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.11.4 AORTEC Artificial Vascular Grafts Product Portfolio
6.11.5 AORTEC Recent Developments/Updates
6.12 CryoLife
6.12.1 CryoLife Corporation Information
6.12.2 CryoLife Artificial Vascular Grafts Description and Business Overview
6.12.3 CryoLife Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.12.4 CryoLife Artificial Vascular Grafts Product Portfolio
6.12.5 CryoLife Recent Developments/Updates
6.13 LifeNet Health
6.13.1 LifeNet Health Corporation Information
6.13.2 LifeNet Health Artificial Vascular Grafts Description and Business Overview
6.13.3 LifeNet Health Artificial Vascular Grafts Sales, Revenue and Gross Margin (2019-2024)
6.13.4 LifeNet Health Artificial Vascular Grafts Product Portfolio
6.13.5 LifeNet Health Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Artificial Vascular Grafts Industry Chain Analysis
7.2 Artificial Vascular Grafts Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Artificial Vascular Grafts Production Mode & Process
7.4 Artificial Vascular Grafts Sales and Marketing
7.4.1 Artificial Vascular Grafts Sales Channels
7.4.2 Artificial Vascular Grafts Distributors
7.5 Artificial Vascular Grafts Customers
8 Artificial Vascular Grafts Market Dynamics
8.1 Artificial Vascular Grafts Industry Trends
8.2 Artificial Vascular Grafts Market Drivers
8.3 Artificial Vascular Grafts Market Challenges
8.4 Artificial Vascular Grafts Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
